Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Byrd

Showing results (461-470 of 1,058) with videos related to

Pageof 106
Sort By:
The Journal of Physical Chemistry. A|February 10, 2017
Harmonic Vibrational Frequencies: Approximate Global Scaling Factors for TPSS, M06, and M11 Functional Families Using Several Common Basis SetsD O Kashinski, G M Chase, R G Nelson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2007
Methylation and silencing of protein tyrosine phosphatase receptor type O in chronic lymphocytic leukemiaTasneem Motiwala, Sarmila Majumder, Huban Kutay, et al.
Leukemia Research|January 15, 2020
Outcomes of the cyclophosphamide, vincristine, prednisone (CVP) +/- rituximab (R-CVP) regimen in older patients with newly diagnosed Ph- acute lymphoblastic leukemiaCaner Saygin, Nicole Grieselhuber, James Blachly, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 2012
Novel targeted agents and the need to refine clinical end points in chronic lymphocytic leukemiaBruce D Cheson, John C Byrd, Kanti R Rai, et al.
Molecular Pharmacology|October 21, 2010
Histone deacetylase inhibitors stimulate histone H3 lysine 4 methylation in part via transcriptional repression of histone H3 lysine 4 demethylasesPo-Hsien Huang, Chun-Han Chen, Chih-Chien Chou, et al.
Hemasphere|August 18, 2020
How We Manage Patients With Chronic Lymphocytic Leukemia During the SARS-CoV-2 PandemicDavide Rossi, Mazyar Shadman, Adalgisa Condoluci, et al.
Seminars in Oncology|July 6, 2000
Theophylline, pentostatin (Nipent), and chlorambucil: a dose-escalation study targeting intrinsic biologic resistance mechanisms in patients with relapsed lymphoproliferative disordersJ C Byrd, M R Grever, J K Waselenko, et al.
Plos One|July 11, 2013
Functional Role of mTORC2 versus Integrin-Linked Kinase in Mediating Ser473-Akt Phosphorylation in PTEN-Negative Prostate and Breast Cancer Cell LinesSu-Lin Lee, Chih-Chien Chou, Hsiao-Ching Chuang, et al.
British Journal of Haematology|July 17, 2009
Pretreatment angiogenic cytokines predict response to chemoimmunotherapy in patients with chronic lymphocytic leukaemiaTait D Shanafelt, John C Byrd, Betsy LaPLant, et al.
British Journal of Haematology|February 11, 2019
Ibrutinib provides favourable survival outcomes in patients with comorbidities versus established therapiesJan A Burger, Paula Cramer, Paul M Barr, et al.
Pageof 106

Showing results (461-470 of 1,058) with videos related to

Sort By:
Pageof 106
The Journal of Physical Chemistry. A|February 10, 2017
Harmonic Vibrational Frequencies: Approximate Global Scaling Factors for TPSS, M06, and M11 Functional Families Using Several Common Basis SetsD O Kashinski, G M Chase, R G Nelson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2007
Methylation and silencing of protein tyrosine phosphatase receptor type O in chronic lymphocytic leukemiaTasneem Motiwala, Sarmila Majumder, Huban Kutay, et al.
Leukemia Research|January 15, 2020
Outcomes of the cyclophosphamide, vincristine, prednisone (CVP) +/- rituximab (R-CVP) regimen in older patients with newly diagnosed Ph- acute lymphoblastic leukemiaCaner Saygin, Nicole Grieselhuber, James Blachly, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 2012
Novel targeted agents and the need to refine clinical end points in chronic lymphocytic leukemiaBruce D Cheson, John C Byrd, Kanti R Rai, et al.
Molecular Pharmacology|October 21, 2010
Histone deacetylase inhibitors stimulate histone H3 lysine 4 methylation in part via transcriptional repression of histone H3 lysine 4 demethylasesPo-Hsien Huang, Chun-Han Chen, Chih-Chien Chou, et al.
Hemasphere|August 18, 2020
How We Manage Patients With Chronic Lymphocytic Leukemia During the SARS-CoV-2 PandemicDavide Rossi, Mazyar Shadman, Adalgisa Condoluci, et al.
Seminars in Oncology|July 6, 2000
Theophylline, pentostatin (Nipent), and chlorambucil: a dose-escalation study targeting intrinsic biologic resistance mechanisms in patients with relapsed lymphoproliferative disordersJ C Byrd, M R Grever, J K Waselenko, et al.
Plos One|July 11, 2013
Functional Role of mTORC2 versus Integrin-Linked Kinase in Mediating Ser473-Akt Phosphorylation in PTEN-Negative Prostate and Breast Cancer Cell LinesSu-Lin Lee, Chih-Chien Chou, Hsiao-Ching Chuang, et al.
British Journal of Haematology|July 17, 2009
Pretreatment angiogenic cytokines predict response to chemoimmunotherapy in patients with chronic lymphocytic leukaemiaTait D Shanafelt, John C Byrd, Betsy LaPLant, et al.
British Journal of Haematology|February 11, 2019
Ibrutinib provides favourable survival outcomes in patients with comorbidities versus established therapiesJan A Burger, Paula Cramer, Paul M Barr, et al.
Pageof 106